Pfizer Sales Fall as Company Races Toward Covid-19 Vaccine

  • 📰 WSJ
  • ⏱ Reading Time:
  • 4 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 5%
  • Publisher: 63%

United States News News

United States United States Latest News,United States United States Headlines

Pfizer posted growth in its biopharma division, but overall sales fell amid increased competition in its generic-drug business

As the coronavirus continues to spread around the globe, companies and academic labs are racing to develop a vaccine that would help society get back to normal. But there could also be costs to moving too quickly.

WSJ’s Daniela Hernandez explains. Photo illustration: Laura Kammermann
 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

Is Hydroxychloroquine a generic? 🤔

China tortures in East Turkestan 

Everyone suffered drop so its not Pfizer alone but pfizer definitely can withstand this

Everything that happens happens as it should, and if you observe carefully, you will find this to be so.

The generic drug laws were devised to encourage competition and keep prices down. Tough sh!t Pfizer.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 98. in US

United States United States Latest News, United States United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Stocks making the biggest moves after hours: Pfizer, F5 Networks, Virgin Galactic and moreSee which stocks are posting big moves after the bell.
Source: CNBC - 🏆 12. / 72 Read more »